Key result
MTHFR 677TT genotype linked to increased risk of cervical artery dissection.
Why the study?
The role of the MTHFR C677T polymorphism in modifying the risk for cervical artery dissection was investigated due to unclear genetic risk factors.
Does the MTHFR 677TT genotype increase the risk of cervical artery dissection?
Case-Control (n=1,101)
Does the MTHFR 677TT genotype increase the risk of cervical artery dissection?
The MTHFR C677T polymorphism (TT genotype) is associated with a slightly increased risk of cervical artery dissection, particularly for multiple events.
Answers are grounded in this paper and cite their sources.
MTHFR 677TT was associated with modestly higher CAD risk, especially multiple events; hypothesis-generating and should not yet change practice.
The methylene tetrahydrofolate reductase (MTHFR) C677T polymorphism was studied in 174 German patients with cervical artery dissection (CAD). The results were compared with published data on 927 healthy German controls. In the series of patients, the frequency of T alleles and of TT carriers was slightly higher (13.8%) than among the healthy controls (10.6%). In patients with multiple dissections (n = 50), the proportion of TT carriers (18%) was found to be even higher and correlated with the number of events. The MTHFR C677T polymorphism was suggested to modify the risk for CAD.
No takes yet. Share an insight, caveat, or question.
M. Kloss (2006) conducted a case-control in Cervical artery dissection (n=1,101). MTHFR C677T polymorphism vs. Healthy controls was evaluated on Frequency of TT carriers. The MTHFR 677TT genotype was present in 13.8% of patients with cervical artery dissection compared to 10.6% of healthy controls, suggesting it modifies the risk for CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: